Table 1.
Electrode | Electrode modification | Method of detection | Analyte | Linear range | Limit of detection | Sample medium | Reference |
---|---|---|---|---|---|---|---|
SPE | Uricase/MWCNT | AMP | Uric acid | 5–1000 μM | 0.33 μM | Saliva | [18] |
GC | Cyt c/TPP-HA[TFSI]/MWCNT | AMP | Hydrogen peroxide | 20–892 μM | 6.2 μM | Milk and juice drink | [19] |
Au | PEI/CNT/Ab | Impedance | CA19–9 | – | 0.35 U/mL | Blood serum | [20] |
GC | GDH/MG-Tb@meso | CV | Glucose | 0.025–17 mM | 8 μM | Blood serum | [21] |
GC | phage/PEI-f-CNT | EIS | Escherichia coli B | 103–107 CFU/mL | 103 CFU/mL | Culture broth | [22] |
Au | AuNPs/SWCNTs/PDA | LSV | DNA | 0.1 pM–10 nM | 5.2 fM | Human serum | [23] |
SPE | AuNP/Ab | EIS | E. coli | 15–106 CFU/mL | 15 CFU/mL | PBS | [24] |
Au | hCG-binding peptide | EIS | hCG | 0.001–0.2 IU/mL | 0.6 mIU/mL | Human serum | [25] |
Ag | Au-PtNWA/PtNP/penicillinase | CV | penicillin | 20–310 μM | 10.5 μM | Chicken/beef extract | [26] |
CCE | AuNP/antigen | LSV | TBEV | 50–1600 IU/mL | 50 IU/mL | Immunoglobins | [27] |
GC | GOx/AgNP-MWCNT | DPV | glucose | 0.025–1 mM | 0.01 mM | PBS | [28] |
GC | PANI/CNT/CuNP | LSV | Phthalate esters | – | 0.03–0.08 nM | Bottled drinks, lake water | [29] |
PG | Hb/MWCNT/CuNP/PANI | DPV | acrylamide | 5–75 nM | 0.2 nM | Potato crisps | [30] |
GC | XO/MNP-PAMAM-PtNP/rGO-CMC | AMP | Xanthine | 50 nM–12 μM | 13 nM | Fish samples | [31] |
ITO | Au@PtNP/GO nanozymes | AMP | Hydrogen peroxide | 1–100 μM | 1.62 μM | Artificial urine | [32] |
GC | BNNTs-Pani-Pt-GOD | AMP | Glucose | 0.01–5.5 mM | 6 μM | ND | [33] |
GC | BN/chitosan-Catalase | FIA | Forchlorfenuron | 0.5–10.0 μM | 0.07 μM | Fruits and juice samples | [34] |
GC | BN–Pt NPs-GOD | AMP | Glucose | 0.1–2.7 mM | 14.1 μM | ND | [35] |
GC | Au–Pd NPs@BNNSs/Ab2 | DPV | B. anthracis | 5 pg/mL to 100 ng/mL | 1 pg/mL | culture broth | [36] |
FTO | Apt/AuNP/BNNS | DPV | Myoglobin | 0.1–100 μg/mL | 34.6 ng/mL | Human serum | [37] |
GC | RGO-GOX | AMP | Glucose | 0.1–27 mM | ND | Human serum | [38] |
GC | rGO-AuNR-adriamycin | DPV | Complementary DNA | 1.0 × 10−16 to 1.0 × 10−9 | 3.5 × 10−17 | Human serum | [39] |
GC | NG-Fe3O4-MB | DPV | ssDNA | 1.0 × 10−14 to 1.0 × 10−6 M | 3.63 × 10−15 M | Human Serum | [40] |
GC | 3D-rGO-PANI-ssDNA-MB | DPV | breast cancer BRCA1 | 1.0 × 10−15–1.0 × 10−7 M) | 3.01 × 10−16 M | Blood samples | [41] |
GC | Nafion- GOx-G/AuNP-GC | AMP | Glucose | Low μM up to 30 mM | 1 μM | ND | [42] |
Pt | GO-GOX | AMP | Glucose | 5–22 mM | ND | ND | [43] |
GC | GO-AuNR-MB | DPV | Complementary DNA | 1.0 × 10−14–1.0 × 10−9 | 3.5 × 10−15 | ND | [44] |
GC | 3D GR/AuPtPd | DPV | ctDNA | 0.01 to 500 pM | 0.13 pM | Human serum | [45] |
GC | GO-AuNR-OB | DPV | miR-155 | 2 fM - 8 pM | 0.6 fM | Human plasma | [46] |
PG | GQD/ssDNA | DPV | ssDNA or Thrombin | 200–500 nM | 100 nM | Buffered solution | [47] |
Au | CQD/AuNP-GOx | AMP | Glucose | 0.05–2.85 mM | 17 μM | Human serum | [48] |
CC | GOx-GQD | AMP | Glucose | 5–1270 μM | 1.73 μM | Human plasma | [49] |
GC | DNA/chiCD | DPV |
NDMA NDEA |
9.9–740 nM 9.6–402 nM |
9.9 nM 9.6 nM |
Buffered solution | [50] |
PG | CQD/ctDNA | DPV | DNR | 0.1–0.5 μM | 66 nM | Aqueous solution | [51] |
GC | GOx/Au/MXene/Nafion | AMP | glucose | 0.1–18 mM | 5.9 μM | PBS | [52] |
CFM | CNTs/Ti3C2Tx/PB | AMP | Glucose lactate |
10 μM–1.5 mM 0–22 mM |
0.33 μM 0.67 μM |
Human sweat | [53] |
GC | Ti3C2-HF/TBA/GOx/GTA | AMP | glucose | 50–27,750 μM | 23 μM | Human serum | [54] |
GC | MXene-graphene/GOx | CV | glucose | 0.2–5.5 mM | 0.1 mM | Human serum | [55] |
GC | Ab/MXene | CV | CEA | 0.0001–2000 ng/mL | 0.018 pg/mL | Human serum | [56] |
PEI polyethyleneimine, Ab antibody, CNT carbon nanotube, PDA polydopamine, SWCNT single-walled carbon nanotubes, GDH glucose dehydrogenase, MG methylene green, Cyt c cytochrome c, TPP-HA[TFSI] highly water-insoluble phosphonium-based carboxyl functionalised ionic liquid, MWCNT multi-walled carbon nanotube, SPE screen-printed electrode, FTO fluorine-doped tin oxide electrode, XO xanthine oxidase, MNP magnetic nanoparticles, PAMAM polyamidoamine G-4 dendrimers, CMC carboxymethylcellulose, CCE carbon composite electrode, PANI polyaniline, PG pencil graphite, Hb haemoglobin, Apt aptamer, AuNP gold nanoparticles, BNNS boron nitride nanosheets, GC glassy carbon, GOD glucose oxidase, BNNTs boron nitride nanotubes, AMP amperometric, BN boron nitride, Pt platinum nanoparticles, FIA flow injection analysis, Ab2 anti-B. anthracis Sap antibodies, G graphene, AuNR gold nanorods, OB anthraquinone Oracet Blue, 3D GR 3D graphene, ctDNA circulating tumour DNA, PG pyrolytic graphite, GQD graphene quantum dots, CC carbon ceramin, NDMA N-nitrosodimethylamine, NDEA N-nitrosodiethanolamine, DNR daunorubicin, TBA tetrabutylammonium, GTA glutaraldehyde, CEA carcinoembryonic antigen